Expansion Therapeutics – Expansion Therapeutics

Press Release

Expansion Therapeutics Names Renato Skerlj, Ph.D., Chief Executive Officer and President

Expansion Therapeutics, Inc., a biotechnology company advancing transformative medicines to patients with RNA-mediated diseases, today…

Expansion TherapeuticsOctober 5, 2020

Press Release

Expansion Therapeutics Expands Leadership Team with Two Key Appointments; Names World-Renowned Scientist Lynne E. Maquat, Ph.D., to its Scientific Advisory Board

Additions strengthen management team and position company to advance portfolio of medicines targeting RNA-mediated diseases…

Expansion TherapeuticsJune 17, 2019

Scientists Take Aim at Disease-Causing RNAs Using Small-Molecule Drugs – The Scientist

Expansion Therapeutics Named a 2019 Xconomy Awards San Diego Finalist

Perspectives on Targeting RNA with Small Molecules to Capture Opportunities at the Intersection of Chemistry, Biology, and Medicine – JACS

Expansion into TNBC – BioCentury

Press Release

Expansion Therapeutics Names Elliot Ehrich, M.D., Chief Medical Officer

Former EVP of R&D and Chief Medical Officer at Alkermes joins Expansion to advance portfolio…

Expansion TherapeuticsNovember 13, 2018

Matthew D. Disney, Ph.D., Scientific Founder of ExpansionRx, Named BioFlorida’s Entrepreneur of the Year

Event

Matthew Disney, Ph.D., Presents at the 2018 Myotonic Dystrophy Foundation Annual Conference

Expansion TherapeuticsOctober 4, 2018

Small Molecules Get the Message – Nature Biotechnology